The controlled release of vancomycin in gelatin/β-TCP composite scaffolds

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 9, 2012, Pages 2295-2301

  Zhou, Jian ^a   Fang, Taolin ^a   Wang, Yichao ^a   Dong, Jian ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

composite scaffold; controlled release; osteomyelitis; vancomycin

Indexed keywords

ANTI-MICROBIAL AGENT; BIODEGRADABLE GELATIN SPONGES; COMPOSITE SCAFFOLDS; CONTROLLED RELEASE; DRUG RELEASE; IN-VIVO; LOCAL DELIVERY; ORTHOPAEDIC SURGEONS; OSTEOMYELITIS; SURGICAL TECHNIQUES; SUSTAINED-RELEASE; THERAPEUTIC DRUGS; TRI-CALCIUM PHOSPHATES; VANCOMYCIN;

FOURIER TRANSFORM INFRARED SPECTROSCOPY; MECHANICAL PROPERTIES; SCAFFOLDS (BIOLOGY); SCANNING ELECTRON MICROSCOPY;

SCAFFOLDS;

BETA TRICALCIUM PHOSPHATE CERAMICS; CALCIUM PHOSPHATE CERAMIC; GELATIN SPONGE; TISSUE SCAFFOLD; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC OSTEOMYELITIS; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POROSITY; RAT; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE;

ANIMALS; ANTI-BACTERIAL AGENTS; CALCIUM PHOSPHATES; DELAYED-ACTION PREPARATIONS; GELATIN; HUMANS; OSTEOMYELITIS; POROSITY; RATS; RATS, SPRAGUE-DAWLEY; TISSUE SCAFFOLDS; VANCOMYCIN;

EID: 84864404431     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34170     Document Type: Article

References (30)

1. Lazzarini L, Mader JT, Calhoun JH,. Osteomyelitis in long bones. J Bone Joint Surg Am A 2004; 86: 2305-2318.
2. Gemmell CG, Edwards DI, Fraise AP, Gould FK, Ridgway GL, Warren RE,. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemoth 2006; 57: 589-608.
3. Tanaka KS, Dietrich E, Ciblat S, Metayer C, Arhin FF, Sarmiento I, Moeck G, Parr TR Jr, Far AR,. Synthesis and in vitro evaluation of bisphosphonated glycopeptide prodrugs for the treatment of osteomyelitis. Bioorg Med Chem Lett 2010; 20: 1355-1359.
4. Zilberman M, Elsner JJ,. Antibiotic-eluting medical devices for various applications. J Control Release 2008; 130: 202-215.
5. Wu P, Grainger DW,. Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials 2006; 27: 2450-2467.
6. Buchholz HW, Elson RA, Engelbrecht E, Lodenkämper H, Röttger J, Siegel A,. Management of deep infection of total hip replacement. J Bone Joint Surg Br B 1981; 63: 342-353.
7. Hanssen AD,. Local antibiotic delivery vehicles in the treatment of musculoskeletal infection. Clin Orthop Relat Res 2005; 437: 91-96.
8. Zekorn D,. Intravascular retention, dispersal, excretion and breakdown of gelatin plasma substitutes. Bibliog Haemat 1969; 33: 131-140.
9. Young S, Wong M, Tabata Y, Mikos AG,. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release 2005; 109: 256-274.
10. Liu Y, Lu Y, Tian XZ, Cui G, Zhao YM, Yang Q,. Segmental bone regeneration using an rhBMP-2-loaded gelatin/nanohydroxyapatite/fibrin scaffold in a rabbit model. Biomaterials 2009; 30: 6276-6285.
11. Matsumoto G, Omi Y, Kubota E, Ozono S, Tsuzuki H, Kinoshita Y, Tabata Y,. Enhanced regeneration of critical bone defects using a biodegradable gelatin sponge and b-tricalcium phosphate with bone morphogenetic protein-2. J Biomater Appl 2009; 24: 327-343.
12. Takahashi Y, Yamamoto M, Tabata Y,. Osteogenic differentiation of mesenchymal stem cells in biodegradable sponges composed of gelatin and b-tricalcium phosphate. Biomaterials 2005; 26: 3587-3596.
13. Itoh S, Kikuchi M, Koyama Y, Takakuda K, Shinomiya K, Tanaka J,. Development of an artificial vertebral body using a novel biomaterial, hydroxyapatite/collagen composite. Biomaterials 2002; 23: 3919-3926.
14. Takahashi Y, Yamamoto M, Tabata Y,. Osteogenic differentiation of mesenchymal stem cells in biodegradable sponges composed of gelatin and b-tricalcium phosphate. Biomaterials 2005; 26: 3587-3596.
15. Yaszemski MJ, Payne RG, Hayes WC, Langer R, Mikos AG,. Evolution of bone transplantation: Molecular, cellular and tissue strategies to engineer human bone. Biomaterials 1996; 17: 175-185.
16. Panzavolta S, Fini M, Nicoletti A, Bracci B, Rubini K, Giardino R, Bigi A,. Porous composite scaffolds based on gelatin and partially hydrolyzed a-tricalcium phosphate. Acta Biomater 2009; 5: 636-643.
17. Chen GP, Ushida T, Tateishi T,. A biodegradable hybrid sponge nested with collagen microsponges. J Biomed Mater Res 2000; 51: 273-279.
18. Donelli G, Francolini I, Piozzi A, Rosa RD, Marconi W,. New polymer-antibiotic systems to inhibit bacterial biofilm formation: A suitable approach to prevent central venous catheter-associated infections. J Chemotherapy 2002; 14: 501-507.
19. Wang YC, Uemura T, Dong J, Kojima H, Tanaka J, Tateishi T,. Application of perfusion culture improves in vitro and in vivo osteogenesis of bone marrow-derived osteoblatic cells in porous ceramics materials. Tissue Eng 2003; 9: 1205-1214.
20. Dong J, Uemura T, Shirasaki Y, Tateishi T,. Promotion of bone formation using highly pure porous β-TCP combined with mesenchymal stem cells. Biomaterials 2002; 23: 4493-4502.
21. Chen KY, Shyu PC, Dong GC, Chen YS, Kuo WW, Yao CH,. Reconstruction of calvarial defect using a tricalcium phosphate-oligomeric proanthocyanidins cross-linked gelatin composite. Biomaterials 2009; 30: 1682-1688.
22. Yao CH, Liu BS, Hsu SH, Chen YS,. Calvarial bone response to a tricalcium phosphate-genipin crosslinkedgelatin composite. Biomaterials 2005; 26: 3065-3074.
23. Weinand C, Nabili A, Khumar M, Dunn JR, Ramella-Roman J, Jeng JC, Jordan MH, Tabata Y,. Factors of osteogenesis influencing various human stem cells on third-generation gelatin/b-tricalcium phosphate scaffold material. Rejuv Res 2011; 14: 185-194.
24. Chang WH, Chang Y, Lai PH, Sung HW,. A genipin-crosslinked gelatin membrane as wound dressing material: in vitro and in vivo studies. J Biomat Sci Polymer Ed 2003; 14: 481-495.
25. Yao CH, Liu BS, Hsu SH, Chen YS, Tsai CC,. Biocompatibility and biodegradation of a bone composite containing tricalcium phosphate and genipin crosslinked gelatin. J Biomed Mater Res A 2004; 69A: 709-717.
26. Polonio1 RE, Mermel LA, Paquette, GE, Sperry JF,. Eradication of Biofilm-Forming Staphylococcus epidermidis (RP62A) by a combination of sodium salicylate and vancomycin. Antimicrob Agents Ch 2001; 45: 3262-3266.
27. Karageorgiou V, Kaplan D,. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 2005; 26: 5474-5491.
28. Gonzalez B, Colilla M, Vallet-Regi M,. Time-delayed release of bioencapsulates: A novel controlled delivery concept for bone implant technologies. Chem Mater 2008; 20: 4826-4834.
29. Zhou J, Fang TL, Wen JC, Shao ZZ, Dong J,. Silk coating on Poly (ε-caprolactone) microspheres for the delayed release of vancomycin. J Microencapsul 2011; 28: 99-107.
30. Maggio RM, Castellano PM, Kaufman TS,. A new principal component analysis-based approach for testing "similarity" of drug dissolution profiles. Eur J Pharm Sci 2008; 34: 66-77.